Royal DSM, a global science-based company in Nutrition, Health and
Sustainable Living, and digital health provider Panaceutics are joining
forces to bring affordable personalized nutrition products to the
market, providing consumers with access to the specific nutrients they
need for optimal health.
The collaboration will see DSM exclusively market and sell Panaceutics
Nutrition personalized products in multiple markets across the Americas,
Europe and Asia. As one of the only systems in the world that allows
cost-effective and scalable manufacturing of individual formulations,
Panaceutics uses patented technologies to combine digital data on daily
habits, genomics and biomarkers. This then drives its on-demand robotic
manufacturing platform to make an individual’s blended formula,
delivered in a ready-to-consume, shelf-stable packaged product.
The Personalized Nutrition and Wellness segment is expected to see
continued growth, as people become better informed on the importance of
maintaining health and wellbeing. Delivering the right combination of
nutritional ingredients at effective and safe doses, Panaceutics
Nutrition will allow individuals to easily optimize their health in a
way that suits their unique needs.
Peter De-Meester, VP Global Strategy and Personalized Nutrition, DSM,
states: “As consumers become increasingly health-conscious, we believe
personalized nutrition will continue to disrupt the nutrition and
supplement market and grow into a multi-billion-dollar industry.
Realizing this potential and to remain at the forefront of innovation in
this field, we continue to expand and establish new partners in the
space. This includes innovative early stage companies like Panaceutics,
which is making personalized nutrition solutions available to
populations across the world.”
Edison Hudson, CEO and Co-Founder, Panaceutics, added: “Our disruptive
technology uses proprietary robotic technology, in combination with
digital health platforms, to rapidly manufacture products to serve
individuals needs and health conditions. This exciting venture with DSM
will help us to reach our goal of serving large numbers of people with
data-driven personalization.”
In line with the latest consumer preferences, nutritional solutions are
delivered in convenient organic food purees or gel suspensions,
therefore removing the need for individuals to take multiple
supplements. DSM is a minority investor in Panaceutics through its
venture investment arm, DSM Venturing, and the companies will
collaborate on several personalized health projects, including adapting
Panaceutics’ exclusive technology to manufacture additional formats,
such as personalized beverages and bars. Although the partnership with
DSM focuses on personalized nutrition, the Panaceutics technology is
also a significant tool in personalized medicine therapies, where it is
already helping to prevent and manage medical conditions.
DSM – Bright Science. Brighter Living.™
Royal DSM is a purpose-led global science-based company in Nutrition,
Health and Sustainable Living. DSM is driving economic prosperity,
environmental progress and social advances to create sustainable value
for all stakeholders. DSM delivers innovative business solutions for
human nutrition, animal nutrition, personal care and aroma, medical
devices, green products and applications, and new mobility and
connectivity. DSM and its associated companies deliver annual net sales
of about €10 billion with approximately 23,000 employees. The company is
listed on Euronext Amsterdam. More information can be found at www.dsm.com.
Or find us on:
https://www.facebook.com/DSMcompany
https://twitter.com/dsm
https://www.linkedin.com/company/dsm/
https://www.youtube.com/user/dsmcompany
For more information:
DSM www.dsm.com/corporate/home.html
Panaceutics® is the registered trademark of
Panaceutics Nutrition LLC, which is a majority owned subsidiary of
Panacea BioMatx Inc. The Company was founded in March, 2013 in Research
Triangle Park, NC by Edison Hudson, a robotics inventor and entrepreneur
with multiple exits, and Lloyd Staton Noel III, a pharmacologist with 20
years in drug development at Glaxo Smith Kline. The Company’s mission
has been to make the benefits of digital health available as
personalized therapies at a scale that can serve large populations of
consumers or patients. Triangle Compounding Pharmacy became part of the
Company in 2016, bringing a team of expert PharmD’s and pharmacy
knowledge and a history of accredited service to the pharmacy community.
For more information, visit Panaceutics www.panaceutics.com
and www.panaceuticsnutrition.com
or inquire at info@panaceutics.com.
Forward-looking statements
This press release may contain forward-looking statements with respect
to DSM’s future (financial) performance and position. Such statements
are based on current expectations, estimates and projections of DSM and
information currently available to the company. DSM cautions readers
that such statements involve certain risks and uncertainties that are
difficult to predict and therefore it should be understood that many
factors can cause actual performance and position to differ materially
from these statements. DSM has no obligation to update the statements
contained in this press release, unless required by law. The English
language version of the press release is leading.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190422005345/en/